# Apozeal Pharmaceuticals Inc. – FDA Inspection, Feb 7, 2018

Source: https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/cac43cea-0ad1-4497-8efd-7c750e795e59
Source feed: FDA_Inspections

> FDA inspection 1040076 of Apozeal Pharmaceuticals Inc., February 07, 2018. Classification: Official Action Indicated (OAI). 3 citations under 21 CFR part 211. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1040076
- Company Name: Apozeal Pharmaceuticals Inc.
- Inspection Date: 2018-02-07
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Philadelphia District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1287054 - 2025-10-15](https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/5cedf772-ff92-416e-9e31-51a75fbf805a)
- FDA Inspection 1161191 - 2021-12-15
- [FDA Inspection 1085686 - 2019-04-09](https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/a1f553bf-210b-4f01-81a3-d4276c44e2b1)
- FDA Inspection 1073461 - 2018-11-09
- [FDA Inspection 1060369 - 2018-07-26](https://www.keypedia.com/records/fda_inspections/apozeal-pharmaceuticals-inc/cee55502-d071-4de9-a21f-1346cb5d1ccb)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)

Company: https://www.keypedia.com/companies/apozeal-pharmaceuticals-inc/0eae3e34-426a-4c5f-a067-d762962ea916

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8